AzTrials
AzTrials

Anastomosis, Roux-en-YNCT02720718

Comparison of Laparoscopic Traditional and Knotless Sutures

A study testing Stratafix and Vicryl in people with Anastomosis, Roux-en-Y and Surgical Operation With Anastomosis, Bypass or Graft, run by AZ St.-Dimpna Geel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background Excess weight and obesity is the fifth leading risk factor for global death. Bariatric surgery is considered as the only effective long-term treatment for morbid obesity. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Stratafix and Vicryl
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
No sites listed yet
Study dates
Dec 2014to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age >18 years
  • BMI > 40 (morbid obesity) or BMI > 35 with co-morbidities (type 2 diabetes, proven sleep apnoea and/or refractory arterial hypertension)
  • Reasonable attempts at other weight loss techniques
  • Obesity related health problems
  • No psychiatric or drug dependency problems
  • Capable to understand the risks and commitment associated with the surgery
  • Pregnancy not anticipated in the first two years following surgery

Who cannot join

  • No agreement to informed consent

About this study

Official title: Closing the Anastomoses During Laparoscopic Gastric Bypass Surgery: A Comparison of Traditional and Knotless Sutures

Background

Excess weight and obesity is the fifth leading risk factor for global death. Bariatric surgery is considered as the only effective long-term treatment for morbid obesity. Laparoscopic Roux-en-Y gastric bypass is one of the best surgical procedures, since it achieves excellent long-term results with a low complication rate. Intestinal anastomosis is a very complex and time-consuming procedure in laparoscopy, mainly due to the difficulties of knotting the suture in a limited working area. Barbed sutures may enhance this procedure by eliminating the need for knot tying.

Read more

Objective The aim of this study is to compare the safety and efficacy of knotless barbed sutures (Stratafix) and continuous sutures (Vicryl) for closing the gastrojejunal and jejunojejunal anastomosis in obese patients undergoing gastric bypass.

Study design

This is a prospective randomized study. Patients will be randomly assigned to one of two groups: traditional suture group or knotless suture group. Randomization will be realized by sealed envelopes according to a computer-generated sequence of random numbers, which will be opened for the surgeon just before starting the anastomosis. During the surgery the gastrojejunal and jejunojejunal anastomoses will be performed with a stapler (Echelon 45 Endopath) and closed with a traditional (Vicryl) or knotless (Stratafix Unidirectional) suture. The same surgeon, experienced and specialized in laparoscopic gastric bypass technique, will perform all procedures.

Study population

Two hundred patients undergoing laparoscopic Roux-en-Y gastric bypass.

Main study parameters/endpoints

The primary outcome measure will be the rate of anastomosis-related complications (leakage, bleeding, gastric fistula, anastomotic stenosis) at 4 weeks and at 6 months post-op (safety). The secondary outcome measure will be the time spent on closing the gastrojejunal and jejunojejunal anastomosis (efficacy).

Read the detailed description
  1. INTRODUCTION AND RATIONALE Obesity Excess weight and obesity is the fifth leading risk factor for global death (WHO 2011). It has been demonstrated that conservative treatment of obesity, such as restricting calorie intake, increasing physical activity, and medical treatment, did not succeed in achieving significant long-lasting loss of weight (Flegal 2002). Therefore, bariatric surgery is considered as the only effective long-term treatment for morbid obesity to achieve substantial and sustainable weight loss (Fisher 2002). Gastric bypass Gastric bypass has a two-way effect: it restricts how much food the stomach can hold (restrictive) and it affects how food and calories are absorbed into the bloodstream (malabsorptive). This combination surgery has the highest success rate for amount of weight loss. Laparoscopic Roux-en-Y gastric bypass is one of the best surgical procedures, since it achieves excellent long-term results with a low complication rate (Schauer 2003, Suter 2011, Fisher 2002). During this procedure two anastomoses - gastrojejunal and jejunojejunal -are constructed. This can be achieved with handsewn suturing or with mechanical stapling (Gonzalez 2003). If the anastomoses are stapled with a linear technique, closing of the enterotomies with sutures is still required. This is a very complex and time-consuming procedure in laparoscopy, mainly due to the difficulties of knotting the suture in a limited working area (De Blasi 2013). Knotless sutures Barbed sutures may enhance the suturing procedure by eliminating the need for knot tying and by minimizing the help needed from an assistant. However, only a limited number of studies have examined the use of barbed sutures during gastric bypass procedures (De Blasi 2013, Facy 2013, Costantino 2013, Milone 2013). The aim of this study is to compare the safety and efficacy of knotless barbed sutures and traditional continuous sutures for closing the gastrojejunal and jejunojejunal anastomosis after linear stapling in obese patients undergoing gastric bypass.
  2. OBJECTIVES The aim of this study is to compare the safety and efficacy of knotless barbed sutures (Stratafix Unidirectional) and traditional continuous sutures (Vicryl) for closing the gastrojejunal and jejunojejunal anastomosis in obese patients undergoing gastric bypass.
  3. STUDY DESIGN This is a prospective randomized study. Patients will be included and enrolled in the study after written informed consent. Then, participants will be randomly assigned to one of two groups:
  • Traditional suture group (Vicryl, 2/0)
  • Knotless suture group (Stratafix Unidirectional, 2/0) Randomization will be realized by sealed envelopes according to a computer-generated sequence of random numbers, which will be opened for the surgeon just before starting the anastomosis. The surgical procedure will be a standardized laparoscopic Roux-en-Y gastric bypass with the surgeon positioned between the patients legs. During the surgery the gastrojejunal and jejunojejunal anastomoses will be performed with a linear stapler (Echelon 60 EndopathTM) and closed with a traditional (Vicryl) or knotless (Stratafix Unidirectional) suture. The same surgeon, experienced and specialized in laparoscopic gastric bypass technique, will perform all procedures, supported by 1 assistant and 1 research nurse.
  1. STUDY POPULATION 4.1 Population (base) Two hundred patients undergoing a laparoscopic Roux-en-Y gastric bypass at the AZ St. Dimpna in Geel (Belgium). 4.2 Sample size We have chosen for a sample size of 200 patients (100 in each group). Current literature shows that is a feasible amount of participants for this kind of studies.
  2. METHODS

5.1 Study parameters/endpoints

The primary outcome measure will be the rate of anastomosis-related complications (leakage, bleeding, gastric fistula, anastomotic stenosis) for each group:

  • At 4 weeks post-op: short-term safety
  • At 6 months post-op: long-term safety

The secondary outcome measure will be the time spent on closing the anastomosis (efficacy), measured from first needle in until last knot (Vicryl) or last stitch (Stratafix):

  • Gastrojejunal anastomosis
  • Jejunojejunal anastomosis

Furthermore, we will register the following co-founders:

  • Length of hospital stay
  • Total procedure time
  • Primary or secondary gastric bypass procedure
  • Age
  • Gender
  • BMI
  • ASA score (American Society of Anaesthesiology)
  • Co-morbidities (e.g. diabetes)

5.2 Randomisation, blinding and treatment allocation Then, participants will be randomly assigned to one of two groups: traditional suture group or knotless suture group. Randomization will be realized by sealed envelopes according to a computer-generated sequence of random numbers, which will be opened for the surgeon just before starting the anastomosis.

5.3 Study procedures Patients will be included and enrolled in the study after written informed consent.

The surgical procedure will be a standardized laparoscopic Roux-en-Y gastric bypass using a five-port-site technique (2 x 12 mm; 3 x 5 mm), with the following steps:

  • Division of the stomach:
  1. Horizontally using a 60-mm regular linear stapler with a blue cartridge (Echelon 60 ENDOPATHTM Stapler Ethicon, Endo-Surgery)
  2. Vertically using two 60-mm regular linear staplers with a blue cartridge (Echelon 60 ENDOPATHTM Stapler Ethicon, Endo-Surgery) to reach the angle of His
  • Gastrojejunal anastomosis:
  1. A 60-cm ileal loop is lifted up to the pouch and the anastomosis is performed using 20 mm of a 60-mm regular linear stapler with a blue cartridge (Echelon 60 ENDOPATHTM Stapler Ethicon, Endo-Surgery)
  2. Single-layer continuous suture (Vicryl 2/0 or Stratafix) to close the anastomosis
  • Jejunojejunal anastomosis:
  1. The Roux limb is measured at 100 cm (if the patient has a BMI < 50) or at 150 cm (if the patient has a BMI > 50). The anastomosis is performed using a 60-mm regular linear stapler with a white cartridge (Echelon 60 ENDOPATHTM Stapler Ethicon, Endo-Surgery)
  2. Single-layer continuous suture (Vicryl 2/0 or Stratafix) to close the anastomosis
  • Completion of bowel division using a 60-mm regular linear stapler with a white cartridge (Echelon 60 ENDOPATHTM Stapler Ethicon, Endo-Surgery)

Afterwards, the mesentery defect and the Petersen's defect are closed using a monofilament non-absorbable suture (Prolene 20). De port sites are not closed.

Patients will be evaluated at 4 weeks and 6 months after the surgery to check for complications.

5.4 Withdrawal of individual subjects Subjects can leave the study at any time for any reason if they wish to do so without any consequences. The investigator can decide to withdraw a subject from the study for urgent medical reasons.

  1. STATISTICAL ANALYSIS

6.1 Descriptive statistics Subject characteristics (age, BMI, co-morbidities) will be described as means ± standard error of the mean for each group. Gender will be described as percentage women for each group.

6.2 Statistical analysis All data will be analyzed using SPSS statistical software.

Continuous variables will be compared amongst the two groups by means of an independent Student's t-test:

  • Gastrojejunal anastomosis time
  • Jejunojejunal anastomosis time
  • Total procedure time
  • Length of hospital stay
  • Age
  • BMI
  • ASA score

Categorical variables will be compared by means of a chi-squared test:

  • Complication rate
  • Primary or secondary gastric bypass
  • Gender
  • Co-morbidities

A P-value < 0.05 will be considered statistically significant.

Being tested
Stratafix, Vicryl
Keywords
Gastric Bypass Status for Obesity Complicating Pregnancy, Childbirth and the Puerperium, Laparoscopy, Suture Techniques, Sutures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • StratafixDevice

  • VicrylDevice

Study groups in NCT02720718
Study groupRoleWhat they receive
StratafixExperimentalPatients undergoing laparoscopic RYGB (antecolic, antegastric, "linear anastomosis-technique") using unidirectional barbed (knotless) sutures: Stratafix Unidirectional 2/0.
Receives: Device: Stratafix
VicrylActive comparatorPatients undergoing laparoscopic RYGB (antecolic, antegastric, "linear anastomosis-technique") using classic sutures: Vicryl 2/0.
Receives: Device: Vicryl

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Complication rate.

    Complications encountered postoperatively: leakage, stenosis, bleeding and gastric fistula.

    Measured: Up until 6 months after surgery.

Secondary outcomes (4)
  1. Length of hospital stay.

    Time between admission and discharge from the hospital.

    Measured: Through study completion, an average of 3 days.

  2. Total procedure time.

    Time to complete surgery.

    Measured: intraoperative

  3. Jejunojejunal anastomosis time.

    Time to complete the jejunojejunal anastomosis.

    Measured: intraoperative

  4. Gastrojejunal anastomosis time.

    Time to complete the gastrojejunal anastomosis.

    Measured: intraoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Mar 2016 (estimated)
  2. Study startDec 2014
  3. Primary completionSep 2015
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02720718
Sponsor's protocol ID
Strat-001
Status last verified
Feb 2017
First submitted
11 Mar 2016
Last updated
3 Mar 2017
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Undecided

Publications

  • Costantino F, Dente M, Perrin P, Sarhan FA, Keller P. Barbed unidirectional V-Loc 180 suture in laparoscopic Roux-en-Y gastric bypass: a study comparing unidirectional barbed monofilament and multifilament absorbable suture. Surg Endosc. 2013 Oct;27(10):3846-51. doi: 10.1007/s00464-013-2993-5. Epub 2013 May 31.

    PubMed 23722892
  • De Blasi V, Facy O, Goergen M, Poulain V, De Magistris L, Azagra JS. Barbed versus usual suture for closure of the gastrojejunal anastomosis in laparoscopic gastric bypass: a comparative trial. Obes Surg. 2013 Jan;23(1):60-3. doi: 10.1007/s11695-012-0763-4.

    PubMed 22968833
  • Facy O, De Blasi V, Goergen M, Arru L, De Magistris L, Azagra JS. Laparoscopic gastrointestinal anastomoses using knotless barbed sutures are safe and reproducible: a single-center experience with 201 patients. Surg Endosc. 2013 Oct;27(10):3841-5. doi: 10.1007/s00464-013-2992-6. Epub 2013 May 14.

    PubMed 23670743
  • Fisher BL, Schauer P. Medical and surgical options in the treatment of severe obesity. Am J Surg. 2002 Dec;184(6B):9S-16S. doi: 10.1016/s0002-9610(02)01173-x.

    PubMed 12527344
  • Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002 Oct 9;288(14):1723-7. doi: 10.1001/jama.288.14.1723.

    PubMed 12365955
  • Gonzalez R, Lin E, Venkatesh KR, Bowers SP, Smith CD. Gastrojejunostomy during laparoscopic gastric bypass: analysis of 3 techniques. Arch Surg. 2003 Feb;138(2):181-4. doi: 10.1001/archsurg.138.2.181.

    PubMed 12578417
  • Milone M, Di Minno MN, Galloro G, Maietta P, Bianco P, Milone F, Musella M. Safety and efficacy of barbed suture for gastrointestinal suture: a prospective and randomized study on obese patients undergoing gastric bypass. J Laparoendosc Adv Surg Tech A. 2013 Sep;23(9):756-9. doi: 10.1089/lap.2013.0030. Epub 2013 Jul 16.

    PubMed 23859743
  • Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003 Oct;238(4):467-84; discussion 84-5. doi: 10.1097/01.sla.0000089851.41115.1b.

    PubMed 14530719
  • Suter M, Donadini A, Romy S, Demartines N, Giusti V. Laparoscopic Roux-en-Y gastric bypass: significant long-term weight loss, improvement of obesity-related comorbidities and quality of life. Ann Surg. 2011 Aug;254(2):267-73. doi: 10.1097/SLA.0b013e3182263b66.

    PubMed 21772127
  • Gys B, Gys T, Lafullarde T. The Use of Unidirectional Knotless Barbed Suture for Enterotomy Closure in Roux-en-Y Gastric Bypass: a Randomized Comparative Study. Obes Surg. 2017 Aug;27(8):2159-2163. doi: 10.1007/s11695-017-2628-3.

    PubMed 28281235

Questions about this trial

What is this clinical trial studying?

A study testing Stratafix and Vicryl in people with Anastomosis, Roux-en-Y and Surgical Operation With Anastomosis, Bypass or Graft, run by AZ St.-Dimpna Geel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Mar 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Complication rate. (time frame: Up until 6 months after surgery.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02720718, which also lists 10 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in